Distinct actions of the fermented beverage kefir on host behaviour, immunity and microbiome gut-brain modules in the mouse
Open accessPublished version of a preprint
Abstract
Background: Mounting evidence suggests a role for the gut microbiota in modulating brain physiology and behaviour, through bi-directional communication, along the gut-brain axis. As such, the gut microbiota represents a potential therapeutic target for influencing centrally mediated events and host behaviour. It is thus notable that the fermented milk beverage kefir has recently been shown to modulate the composition of the gut microbiota in mice. It is unclear whether kefirs have differential effects on microbiota-gut-brain axis and whether they can modulate host behaviour per se. Methods: To address this, two distinct kefirs (Fr1 and UK4), or unfermented milk control, were administered to mice that underwent a battery of tests to characterise their behavioural phenotype. In addition, shotgun metagenomic sequencing of ileal, caecal and faecal matter was performed, as was faecal metabolome analysis. Finally, systemic immunity measures and gut serotonin levels were assessed. Statistical analyses were performed by ANOVA followed by Dunnett's post hoc test or Kruskal-Wallis test followed by Mann-Whitney U test. Results: Fr1 ameliorated the stress-induced decrease in serotonergic signalling in the colon and reward-seeking behaviour in the saccharin preference test. On the other hand, UK4 decreased repetitive behaviour and ameliorated stress-induced deficits in reward-seeking behaviour. Furthermore, UK4 increased fear-dependent contextual memory, yet decreased milk gavage-induced improvements in long-term spatial learning. In the peripheral immune system, UK4 increased the prevalence of Treg cells and interleukin 10 levels, whereas Fr1 ameliorated the milk gavage stress-induced elevation in neutrophil levels and CXCL1 levels. Analysis of the gut microbiota revealed that both kefirs significantly changed the composition and functional capacity of the host microbiota, where specific bacterial species were changed in a kefir-dependent manner. Furthermore, both kefirs increased the capacity of the gut microbiota to produce GABA, which was linked to an increased prevalence in Lactobacillus reuteri . Conclusions: Altogether, these data show that kefir can signal through the microbiota-gut-immune-brain axis and modulate host behaviour. In addition, different kefirs may direct the microbiota toward distinct immunological and behavioural modulatory effects. These results indicate that kefir can positively modulate specific aspects of the microbiota-gut-brain axis and support the broadening of the definition of psychobiotic to include kefir fermented foods.
AI snapshot
Written from the paper’s full text.
TL;DR
Two distinct kefirs (Fr1 and UK4) were administered to mice and produced partly divergent effects on behaviour, peripheral immunity, gut serotonin, and microbiota function. Both kefirs altered the gut microbiota and increased predicted GABA-producing capacity linked to *Lactobacillus reuteri*, supporting kefir as a potential psychobiotic fermented food.
Key findings
- UK4 decreased repetitive behaviour in the marble burying test (F(2,35) = 5.464, p = 0.009), increased fear-dependent contextual memory (trend: F(2,34) = 3.181, p = 0.055), but worsened reversal learning in the appetitive Y-maze (treatment effect: F(2,33) = 3.870, p = 0.031).
- Fr1 increased saccharin preference (χ2(2) = 12.826, p = 0.002) and ameliorated stress-induced changes in colonic serotonergic signalling (5-HT: F(2,35) = 6.387, p = 0.005; 5HIAA/5-HT ratio: F(2,35) = 9.026, p < 0.001).
- UK4 increased mesenteric lymph node Treg cells (F(2,34) = 8.709, p < 0.001), circulating Treg cells (F(2,31) = 3.420, p = 0.046), and plasma IL-10 (F(2,32) = 6.205, p = 0.006); Fr1 reduced milk gavage-induced neutrophil levels (F(2,34) = 5.412, p = 0.009) and CXCL1 (F(2,32) = 7.006, p = 0.003).
- Both kefirs changed microbiota composition and function: 15 bacterial species were differentially abundant, 59 level-4 EC categories differed, and faecal “GABA synthesis III” was higher with Fr1 (LDA = 4.39) and UK4 (LDA = 4.21), attributed to increased *L. reuteri*.
Methods
- Male C57BL/6j mice (8 weeks old; n = 12/group, n = 48 total) received milk control, kefir Fr1, kefir UK4, or no gavage for 3 weeks before a behavioural battery, with tissues collected postmortem.
- Shotgun metagenomic sequencing was performed on ileal, caecal, and faecal matter; faecal metabolome was analysed by GC-MS; immunity was assessed by flow cytometry and cytokine quantification; gut serotonin was measured by HPLC.
- Behavioural/physiological data used ANOVA with Dunnett’s post hoc or Kruskal-Wallis with Mann-Whitney U tests; microbiota analyses used PERMANOVA, LEfSe, HAllA, StrainPhlAn/PanPhlAn, HUMAnN2, and flux variability analysis.
Limitations
- The paper states that it remains unclear whether gut-derived GABA can cross the blood-brain barrier or whether increasing gut-derived GABA improves mood, and that more research is warranted to validate whether the proposed microbiota-gut-brain pathways are involved.
- The paper notes weak serotonin-related effects, no corresponding serotonin-related changes in the microbiome/metabolome, no changes in other depressive-like behaviour measures, and no significant faecal metabolite differences after p-value adjustment.
- Evident from the text: findings are from male mice only, kefir-derived strains did not colonise to high levels, many microbiota-immunity/behaviour links are correlational, and faecal metabolome analysis used a subset of animals (n = 6 per group).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 40 cited sources checked · 0 supported · 0 flagged
- Findingown data
UK4 modestly increased reward-seeking behaviour in the female urine sniffing test.
“and modestly increased reward-seeking behaviour in the female urine sniffing test, also often used as a measure of depression-related anhedonia.”
Quote in the paperNot a substantial claim - Findingown data
L. reuteri encodes enzymes and antiporters associated with GABA production.
“Our data additionally reveals that L. reuteri encodes enzymes and antiporters associated with GABA production.”
Quote in the paperSubstantial claim - Findingown data
Kefir-induced increases in L. reuteri levels were linked to an increased capacity to produce GABA.
“Importantly, kefir-induced increases in L. reuteri levels were linked to an increased capacity to produce GABA.”
Quote in the paperSubstantial claim - Findingown data
Fr1 ameliorated stress-induced deficits in colonic serotonergic signalling.
“Our results also reveal that Fr1 ameliorated stress-induced deficits in colonic serotonergic signalling”
Quote in the paperSubstantial claim - Findingown data
UK4 increased predicted GBM inositol synthesis.
“while UK4 increased “inositol synthesis”.”
Quote in the paperNot a substantial claim
- Findingown data
Both kefirs increased the prevalence of L. reuteri, E. plexicaudatum, and B. pseudolongum.
“Our analysis additionally revealed that both kefirs increased the prevalence of L. reuteri, E. plexicaudatum, B. pseudolongum”
Quote in the paperNot a substantial claim - Findingown data
No corresponding serotonin-related changes were observed in the gut microbiome and metabolome.
“no corresponding serotonin-related changes were observed in the gut microbiome and metabolome”
Quote in the paperNot a substantial claim - Findingown data
Both kefirs increased the abundance of Lactobacillus reuteri in one or more region of the gut.
“Both kefirs increase the abundance in or more region in the gut of Lactobacillus reuteri (Fr1, caecum LDA = 4.36, UK4, caecum LDA = 4.02, UK4, faeces LDA = 4.07), Eubacterium plexicaudatum (Fr1, faeces LDA = 3.77, UK4, caecum: LDA = 4.22, UK4, faeces LDA = 3.67), Bifidobacterium pseudolongum (Fr1, ileum LDA = 4.93, UK4, caecum LDA = 4.7).”
Quote in the paperNot a substantial claim - Findingown data
No changes were observed in other measures of depressive-like behaviour.
“It is important to note, however, that no changes were observed in other measures of depressive-like behaviour.”
Quote in the paperNot a substantial claim - Findingown data
Administration of UK4 decreased the number of marbles buried, indicative of reduced repetitive behaviour.
“In the marble burying test, we found that administration of UK4 decreased the number of marbles buried indicative of reduced repetitive behaviour (F(2,35) = 5.464, p = 0.009) (Fig. 1a).”
Quote in the paperSubstantial claim - Findingown data
UK4 increased fear-dependent contextual memory.
“yet increased fear-dependent contextual memory”
Quote in the paperNot a substantial claim - Findingown data
Levels of faecal metabolites associated with GABA synthesis (2-oxoglutarate, glutamate and succinate) correlate with L. reuteri abundances.
“Furthermore, levels of faecal metabolites associated with GABA synthesis (i.e. 2-oxoglutarate, glutamate and succinate) correlate with L. reuteri abundances.”
Quote in the paperSubstantial claim - Findingown data
Ileal C. Arthromitus unclassified abundances correlated with circulating Treg cell levels.
“In tandem, ileal C. Arthromitus unclassified abundances correlated with circulating Treg cell levels”
Quote in the paperSubstantial claim - Findingown data
No other changes in alpha diversity were observed in any other region or comparison.
“but no other changes in alpha diversity were observed in any other region or comparison.”
Quote in the paperNot a substantial claim - Findingown data
Both Fr1 and UK4 ameliorated the milk-induced decrease in time interacting with the water-containing cotton bulb in the female urine sniffing test.
“In the female urine sniffing test of reward-seeking, mice receiving milk spent less time interacting with the cotton bulb containing water compared to undisturbed mice (χ2(1) = 6.367, p = 0.012), which was ameliorated by both Fr1 and UK4 (χ2(2) = 13.238, p < 0.001) (Fig. 1b).”
Quote in the paperSubstantial claim - Findingown data
None of the bacterial strains present in the kefir microbiota were detected in the gut microbiota of mice receiving kefir.
“Notably, none of the bacterial strains present in the kefir microbiota were detected in the gut microbiota of mice receiving kefir”
Quote in the paperSubstantial claim - Findingown data
UK4 decreased repetitive behaviour.
“In tandem, UK4 decreased repetitive behaviour”
Quote in the paperSubstantial claim - Findingown data
UK4 increased alpha diversity in the caecum.
“Analysis of the gut microbiota revealed that UK4 increased alpha diversity in the caecum”
Quote in the paperNot a substantial claim - Findingown data
UK4 increased prevalence of Alistipes unclassified.
“Some of the other changes in the composition of the microbiota were specific to UK4, such as an increased prevalence of Alistipes unclassified”
Quote in the paperNot a substantial claim - Findingown data
Both kefirs decreased the prevalence of L. bacterium 3_1_46FAA, P. acnes, and B. amyloliquefaciens.
“while decreasing of L. bacterium 3_1_46FAA, P. acnes, and B. amyloliquefaciens.”
Quote in the paperNot a substantial claim - Findingown data
Fr1 increased reward-seeking behaviour in the saccharin preference test.
“Fr1 increased reward-seeking behaviour in the saccharin preference test.”
Quote in the paperSubstantial claim - Findingown data
UK4 decreased C. Arthromitus unclassified.
“and decreased C. Arthromitus unclassified.”
Quote in the paperNot a substantial claim - Findingown data
Fr1 increased B. pseudolongum abundances in the ileum.
“In addition, Fr1 increased B. pseudolongum abundances in the ileum”
Quote in the paperSubstantial claim - Findingown data
The determined effects on colonic serotonergic signalling were weak.
“the determined effects were weak”
Quote in the paperNot a substantial claim - Findingown data
Increase in P. goldsteinii abundance was linked to an increase in GBM S-adenosylmethionine synthesis.
“The increase in P. goldsteinii abundances were linked to an increase in the GBM “S-adenosylmethionine synthesis”.”
Quote in the paperSubstantial claim - Findingown data
UK4 increased the prevalence of T regulatory cells (Treg) cells in mesenteric lymph nodes (MLNs).
“UK4 increased the prevalence of T regulatory cells (Treg) cells in mesenteric lymph nodes (MLNs) (F(2,34) = 8.709, p < 0.001) (Fig. 3c), an anti-inflammatory T helper cell subset known to be induced by gut microbial metabolites [80].”
Quote in the paperSubstantial claim - Findingown data
Ileal B. pseudolongum abundances correlated with circulating neutrophil levels.
“In tandem, ileal B. pseudolongum abundances correlated with circulating neutrophil levels”
Quote in the paperSubstantial claim - Findingown data
UK4 decreased milk gavage-induced improvements in long-term spatial learning.
“UK4 also decreased milk gavage-induced improvements in long-term spatial learning”
Quote in the paperSubstantial claim - Findingown data
UK4 increased B. pseudolongum abundances in the caecum.
“whereas UK4 increased B. pseudolongum abundances in the caecum.”
Quote in the paperNot a substantial claim - Findingnone given
Kefir influenced specific gut microbial functional capacities, including the biosynthesis of various neuroactives such as GABA.
“Furthermore, kefir influenced specific gut microbial functional capacities, including the biosynthesis of various neuroactives such as GABA.”
Quote in the paperSubstantial claim - Findingnone given
Both kefirs differentially affected repetitive behaviour and reward-associated behaviour.
“In addition, both kefirs differentially affected repetitive behaviour and reward-associated behaviour.”
Quote in the paperSubstantial claim - Findingreasoning
Kefirs differentially impacted systemic immunity and colonic serotonergic signalling.
“In line with these findings, kefirs differentially impacted systemic immunity and colonic serotonergic signalling.”
Quote in the paperSubstantial claim - Findingnone given
Both kefirs increased reward-seeking behaviour.
“and that both kefirs increased reward-seeking behaviour.”
Quote in the paperSubstantial claim - Premisecitation
The gastrointestinal microbiota influences host behaviour via bi-directional communication through the microbiota-gut-brain axis.
“Mounting evidence suggests that the gastrointestinal microbiota influences host behaviour via bi-directional communication through what has been coined the microbiota-gut-brain axis [17, 18, 20, 29, 50, 60, 71].”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [17] Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10(11):735–42. source
Not checked in the free run.
- cites [18] Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–12. source
Not checked in the free run.
- cites [20] Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O'Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99(4):1877–2013. source
Not checked in the free run.
- cites [29] Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol Stress. 2017;7:124–36. source
Not checked in the free run.
- cites [50] Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014;34(46):15490. source
Not checked in the free run.
- cites [60] Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6(5):306–14. source
Not checked in the free run.
- cites [71] Sherwin E, Bordenstein SR, Quinn JL, Dinan TG, Cryan JF. Microbiota and the social brain. Science. 2019;366(6465). source
Not checked in the free run.
- Interpretationreasoning
Enhancing GABA production in the gut might be associated with anxiety- and depressive-like behaviour.
“indicating that enhancing GABA production in the gut might be associated with anxiety- and depressive-like behaviour.”
Quote in the paperSubstantial claim - Premisecitation
Supplementation of L. kefiri CIDCA 8348 results in increased gene expression of IL-10 in the ileum and MLNs in mice.
“Notably, supplementation of L. kefiri CIDCA 8348 results in increased gene expression of IL-10 in the ileum and MLNs in mice [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Carasi P, Racedo SM, Jacquot C, Romanin DE, Serradell MA, Urdaci MC. Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res. 2015;2015:361604. source
Not checked in the free run.
- Interpretationreasoning
B. pseudolongum abundances in the ileum might contribute to the decrease in neutrophil levels observed in mice receiving Fr1.
“indicating that B. pseudolongum abundances in the ileum specifically, might contribute to the decrease in neutrophil levels observed in mice receiving Fr1.”
Quote in the paperNot a substantial claim - Interpretationown data
The kefir microbiota did not colonise to high levels.
“indicating that the kefir microbiota did not colonise to high levels.”
Quote in the paperSubstantial claim - Interpretationreasoning
C. Arthromitus unclassified is likely contributing to the increase in Treg cell levels induced by UK4.
“indicating that this bacterial species is likely contributing to the increase in Treg cell levels induced by UK4.”
Quote in the paperNot a substantial claim - Interpretationown data
Not all behavioural effects induced by kefir are positive.
“indicating that not all behavioural effects induced by kefir are positive.”
Quote in the paperSubstantial claim - Interpretationreasoning
Changes in the gut microbiota function and peripheral immunity might contribute to the kefir-induced behavioural phenotype.
“These changes in the gut microbiota function and peripheral immunity might contribute to the kefir-induced behavioural phenotype”
Quote in the paperSubstantial claim - Interpretationown data
Kefir can modulate specific aspects of the microbiota-gut-brain axis in mice.
“These data demonstrate that kefir can modulate specific aspects of the microbiota-gut-brain axis in mice”
Quote in the paperSubstantial claim
- May combine two claims. 13
- Classified as probably not a substantial claim. 26
May combine two claims.
Findingnone givenFr1 increased circulating neutrophil and CXCL1 levels.
“Furthermore, Fr1 increased circulating neutrophil and CXCL1 levels.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUK4 increased circulating Treg cells and IL-10 levels.
“Finally, UK4 increased circulating Treg cells and IL-10 levels.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBeta diversity showed a trend towards significant separation induced by both Fr1 and UK4, which resulted in a significant separation induced by kefir overall.
“Analysis of beta diversity revealed a trend towards significant separation induced by both Fr1 and UK4, which resulted in a significant separation induced by kefir overall.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth kefirs significantly modulated the functional capacity of the gut microbiota and altered the levels of GBMs, which was related to the prevalence of specific bacterial strains.
“Our data also reveals that both kefirs significantly modulated the functional capacity of the gut microbiota and altered the levels of GBMs, which was related to the prevalence of specific bacterial strains.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFr1 increased abundances of P. goldsteinii, B. intestinalis, and Anaerotruncus unclassified in the gut microbiota.
“We observed some changes in the gut microbiota that were specific to kefir Fr1, such as an increase in P. goldsteinii, B. intestinalis, Anaerotruncus unclassified and P. goldsteinii.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFr1 decreased predicted GBM p-Cresol biosynthesis and inositol synthesis.
“Analysis of GBMs revealed that Fr1 decreased the GBM “p-Cresol biosynthesis” and “inositol synthesis””
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIncrease in predicted S-adenosylmethionine synthesis could indicate increased levels of S-adenosylmethionine, which might have contributed to the Fr1-induced increase in reward-seeking behaviour.
“As such, the increase in predicted S-adenosylmethionine synthesis could indicate increased levels of S-adenosylmethionine, which in turn might have contributed to the Fr1-induced increase in reward-seeking behaviour.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSpecific bacterial species increased by kefir administration, such as B. pseudolongum and L. reuteri, have previously been associated with increased levels of anti-inflammatory cytokine IL-10 in mice and Treg cells in mice and humans, respectively.
“In addition, specific bacterial species that were increased by kefir administration, such as B. pseudolongum and L. reuteri, have previously been associated with increased levels of the anti-inflammatory cytokine IL-10 in mice and Treg cells in mice and humans, respectively [53, 65].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [53] Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. 2018;9:757. source
Not checked in the free run.
- cites [65] Sasajima N, Ogasawara T, Takemura N, Fujiwara R, Watanabe J, Sonoyama K. Role of intestinal Bifidobacterium pseudolongum in dietary fructo-oligosaccharide inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice. Br J Nutr. 2009;103(4):539–48. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationS-adenosylmethionine supplementation has been studied in numerous randomised controlled trials involving depressed adults.
“S-adenosylmethionine supplementation has been studied in numerous randomised, controlled trials involving depressed adults [36, 70].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, Winer E, Garber J. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010;17(5):908–16. source
Not checked in the free run.
- cites [70] Sharma A, Gerbarg P, Bottiglieri T, Massoumi L, Carpenter LL, Lavretsky H, Muskin PR, Brown RP, Mischoulon D, R. as Work Group of the American Psychiatric Association Council on. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research. J Clin Psychiatry. 2017;78(6):e656–67. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTwo GABA-producing Lactobacillus strains have recently been shown to reduce depressive-like behaviour in high fat diet-induced obese mice.
“Indeed, two GABA-producing Lactobacillus strains have recently been shown to reduce depressive-like behaviour in high fat diet-induced obese mice [58].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Patterson E, Ryan PM, Wiley N, Carafa I, Sherwin E, Moloney G, Franciosi E, Mandal R, Wishart DS, Tuohy K, Ross RP, Cryan JF, Dinan TG, Stanton C. Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome. Sci Rep. 2019;9(1):16323. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationProbiotics most frequently do not colonise the gut.
“This has parallels with the fact that probiotics most frequently do not colonise the gut [21].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Derrien M, van Hylckama Vlieg JE. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23(6):354–66. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGABA is the primary inhibitory neurotransmitter in the brain.
“GABA is the primary inhibitory neurotransmitter in the brain and central GABA levels have been linked to anxiety and depression [7]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Bienenstock J, Forsythe P, Karimi K, Kunze W. Neuroimmune aspects of food intake. Int Dairy J. 2010;20(4):253–8. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPrevious reports have demonstrated an increased prevalence of Lactobacillus species in response to kefir supplementation, as well as L. kefiri CIDCA 8348 administration.
“Notably, previous reports have also demonstrated an increased prevalence of Lactobacillus species in response to kefir supplementation [40], as well as L. kefiri CIDCA 8348 administration, a species frequently found in kefir [15].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] Kim DH, Kim H, Jeong D, Kang IB, Chon JW, Kim HS, Song KY, Seo KH. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. J Nutr Biochem. 2017;44:35–43. source
Not checked in the free run.
- cites [15] Carasi P, Racedo SM, Jacquot C, Romanin DE, Serradell MA, Urdaci MC. Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res. 2015;2015:361604. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationVarious Lactobacillus strains, or Lactobacillus-containing supplements, have been shown to reduce depressive-like behaviour in rodents and improve measures of depression in humans.
“Various Lactobacillus strains, or Lactobacillus-containing supplements, have been shown to reduce depressive-like behaviour in rodents [1, 13, 23, 44, 45] and improve measures of depression in humans [3, 5, 39, 76].”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [1] Abildgaard A, Elfving B, Hokland M, Wegener G, Lund S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology. 2017;79:40–8. source
Not checked in the free run.
- cites [13] Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–5. source
Not checked in the free run.
- cites [23] Dhaliwal J, Singh DP, Singh S, Pinnaka AK, Boparai RK, Bishnoi M, Kondepudi KK, Chopra K. Lactobacillus plantarum MTCC 9510 supplementation protects from chronic unpredictable and sleep deprivation-induced behaviour, biochemical and selected gut microbial aberrations in mice. J Appl Microbiol. 2018;125(1):257–69. source
Not checked in the free run.
- cites [44] Liang L, Zhou H, Zhang S, Yuan J, Wu H. Effects of gut microbiota disturbance induced in early life on the expression of extrasynaptic GABA-A receptor alpha5 and delta subunits in the hippocampus of adult rats. Brain Res Bull. 2017;135:113–9. source
Not checked in the free run.
- cites [45] Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015;310:561–77. source
Not checked in the free run.
- cites [3] Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, Memarzadeh MR, Asemi Z, Esmaillzadeh A. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32(3):315–20. source
Not checked in the free run.
- cites [5] Bagga D, Reichert JL, Koschutnig K, Aigner CS, Holzer P, Koskinen K, Moissl-Eichinger C, Schopf V. Probiotics drive gut microbiome triggering emotional brain signatures. Gut Microbes. 2018:1–11. source
Not checked in the free run.
- cites [39] Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2019;38(2):522–8. source
Not checked in the free run.
- cites [76] Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015;48:258–64. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationL. reuteri is a bacterial strain that has been ascribed numerous beneficial effects on host immunity and metabolism.
“Notably, L. reuteri is a bacterial strain that has been ascribed numerous beneficial effects on host immunity and metabolism [52, 53].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [52] Mobini R, Tremaroli V, Stahlman M, Karlsson F, Levin M, Ljungberg M, Sohlin M, Berteus Forslund H, Perkins R, Backhed F, Jansson PA. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab. 2017;19(4):579–89. source
Not checked in the free run.
- cites [53] Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. 2018;9:757. source
Not checked in the free run.
May combine two claims.
Interpretationown dataKefir can signal through the microbiota-gut-immune-brain axis and modulate host behaviour.
“Altogether, these data show that kefir can signal through the microbiota-gut-immune-brain axis and modulate host behaviour.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationCentral GABA levels have been linked to anxiety and depression.
“GABA is the primary inhibitory neurotransmitter in the brain and central GABA levels have been linked to anxiety and depression [7]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Bienenstock J, Forsythe P, Karimi K, Kunze W. Neuroimmune aspects of food intake. Int Dairy J. 2010;20(4):253–8. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitationp-Cresol alters neutrophil function in dogs.
“Notably, p-Cresol, of which the predicted biosynthesis was decreased by Fr1, alters neutrophil function in dogs [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Bosco AM, Pereira PP, Almeida BF, Narciso LG, Dos Santos DB, Santos-Neto AJ, Ferreira WL, Ciarlini PC. Free p-Cresol Alters Neutrophil Function in Dogs. Artif Organs. 2016;40(5):480–8. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChanges in the overall composition of the gut microbiota induced by kefir, or kefir-associated bacterial strains, have been reported previously.
“Changes in the overall composition of the gut microbiota induced by kefir, or kefir-associated bacterial strains have been reported previously [15, 30, 34, 40, 90].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [15] Carasi P, Racedo SM, Jacquot C, Romanin DE, Serradell MA, Urdaci MC. Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res. 2015;2015:361604. source
Not checked in the free run.
- cites [30] Gao J, Ding G, Li Q, Gong L, Huang J, Sang Y. Tibet kefir milk decreases fat deposition by regulating the gut microbiota and gene expression of Lpl and Angptl4 in high fat diet-fed rats. Food Res Int. 2019;121:278–87. source
Not checked in the free run.
- cites [34] Hsu YJ, Huang WC, Lin JS, Chen YM, Ho ST, Huang CC, Tung YT. Kefir supplementation modifies gut microbiota composition, reduces physical fatigue, and improves exercise performance in mice. Nutrients. 2018;10(7). source
Not checked in the free run.
- cites [40] Kim DH, Kim H, Jeong D, Kang IB, Chon JW, Kim HS, Song KY, Seo KH. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. J Nutr Biochem. 2017;44:35–43. source
Not checked in the free run.
- cites [90] Yilmaz I, Dolar ME, Ozpinar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol. 2019;30(3):242–53. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLactobacillus strains have previously been reported to produce GABA.
“Indeed, Lactobacillus strains have previously been reported to produce GABA [6, 7, 46].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [6] Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113(2):411–7. source
Not checked in the free run.
- cites [7] Bienenstock J, Forsythe P, Karimi K, Kunze W. Neuroimmune aspects of food intake. Int Dairy J. 2010;20(4):253–8. source
Not checked in the free run.
- cites [46] Lin Q. Submerged fermentation of Lactobacillus rhamnosus YS9 for gamma-aminobutyric acid (GABA) production. Braz J Microbiol. 2013;44(1):183–7. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe order of faecal pellet collection was counterbalanced between groups to minimise the effect of circadian rhythm.
“The order of faecal pellet collection was counterbalanced between groups to minimise the effect of circadian rhythm.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe sequence did not contain more than three consecutive starts in the same position to avoid temporary position preferences.
“This sequence did not contain more than three consecutive starts in the same position to avoid temporary position preferences.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningFood wells were not cleaned between mice so that a slight odour of milk reward remained, ensuring mice found the goal arm based on spatial cues rather than olfactory cues.
“Between mice, the food wells were not cleaned so that a slight odour of milk reward remained at all times, ensuring mice found the goal arm based on spatial cues, rather the olfactory cues.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationAn undisturbed control group was added to control for potential effects of chronic oral gavage or milk administration on behaviour or physiology.
“The last group was added to control for the fact that chronic oral gavage or milk administration could affect behaviour or physiology [87].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Walker MK, Boberg JR, Walsh MT, Wolf V, Trujillo A, Duke MS, Palme R, Felton LA. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice. Toxicol Appl Pharmacol. 2012;260(1):65–9. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThere was a minimum of 36 h between behavioural tests.
“In addition, there was a minimum of 36 h between tests.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe time of testing was counterbalanced between groups and rotated each day to reduce the effect of testing during a specific time of the day.
“The time of testing was counterbalanced between groups and rotated each day to reduce the effect of testing during a specific time of the day.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningBehavioural tests were ordered from least stressful to most stressful to reduce the likelihood of prior behavioural tests influencing subsequent ones.
“which were formed in order of least stressful to most stressful to reduce the likelihood of prior behavioural tests influencing subsequent ones (Fig. 9).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataBehavioural experiments were videotaped and scored blinded.
“All experiments were videotaped using a ceiling-mounted camera and were scored blinded for the time interacted with the wire cup-like cages.”
- Also stated in: § Elevated plus maze · plain
“Experiments were videotaped using a ceiling-mounted camera and videos were scored blinded for time spent in the open arms, which was defined as all paws in the open arm.”
- Also stated in: § Tail-suspension test · plain
“Experiments were videotaped using a numeric tripod-fixed camera and videos were scored blinded for the time mice spent immobile.”
Quote in the paperSubstantial claim- Also stated in: § Elevated plus maze · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe starting position for each trial in the appetitive Y-maze was determined by a pseudorandomised computer sequence.
“The starting position for each trial was determined by a pseudorandomised computer sequence, which was different for each mouse but was the same across treatment groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningMice were habituated to the testing room 40 min before the 3-chamber test to reduce potential anxiogenic factors.
“To reduce potential anxiogenic factors, all mice were habituated to the testing room 40 min before the test”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAnimals were sacrificed by decapitation in a random fashion regarding test groups.
“Animals were sacrificed by decapitation in a random fashion regarding test groups between 9.00 am and 2.00 pm.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe side on which the regular drinking water bottle and the saccharin solution bottle were placed was randomised and counterbalanced between groups.
“The side on which the regular drinking water bottle and the one containing saccharine solution were randomised and counterbalanced between groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAbundances of faecal GABA-producers, such as Bacteroides, correlate negatively with brain signatures associated with depression.
“Furthermore, abundances of faecal GABA-producers, such as Bacteroides, correlate negatively with brain signatures associated with depression [77].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, Mroue N, Liston C, Stewart EJ, Dubin MJ, Zengler K, Knight R, Gilbert JA, Clardy J, Lewis K. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4(3):396–403. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe location of conspecific mice and object were systematically altered between test mice.
“The location of the conspecific mice and object were systemically altered in-between test mice.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenA trial where the mouse did not walk into any arm was excluded from analysis because it indicates the mouse was anxious.
“A trial where the mouse did not walk into any arm was excluded from the analysis, as this indicates that the mouse was anxious.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
It is unclear whether kefirs have differential effects on the microbiota-gut-brain axis and whether they can modulate host behaviour per se.
“It is unclear whether kefirs have differential effects on microbiota-gut-brain axis and whether they can modulate host behaviour per se.”
The paper relies on this without support.
It is not clear if kefirs exert differential influence across the microbiota-gut-brain axis due to their compositional differences.
“It is not clear if kefir’s exert differential influence across the microbiota-gut-brain axis due to their compositional differences [12].”
The paper relies on this without support.
Decreased reward-seeking behaviour (anhedonia) is a key feature of depression.
“Notably, one of the key features of depression is decreased reward-seeking behaviour (i.e. anhedonia)”
“Notably, one of the key features of depression is decreased reward-seeking behaviour (i.e. anhedonia) and that both kefirs increased reward-seeking behaviour.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In mice, kefir administration increased the abundance of L. reuteri, Eubacterium plexicaudatum, and Bifidobacterium pseudolongum, decreased Lachnospiraceae bacterium 3_1_46FAA, Propionibacterium acnes, and Bacillus amyloliquefaciens, and shifted the functional potential of the gut microbiota toward production of neuroactive metabolites.
“In a recent mouse study, kefir administration increased the abundance of L. reuteri, Eubacterium plexicaudatum, and Bifidobacterium pseudolongum, and decreased Lachnospiraceae bacterium 3_1_46FAA, Propionibacterium acnes, and Bacillus amyloliquefaciens, and shifted the functional potential of the gut microbiota toward the production of neuroactive metabolites (58).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [58]
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Inconsistent p-value: t(22) = 2.650, p < .001
MinorThe paper reports p < .001 here; recomputing from the test statistic and its degrees of freedom gives p = .015 (two-tailed). The check cannot tell whether the statistic or the p-value is the misprint.
Reported p < .001 · recomputed p = .015
“t(22) = 2.650, p < 0.001”
Inconsistent p-value: χ2(2) = 13.238, p < .001
MinorThe paper reports p < .001 here; recomputing from the test statistic and its degrees of freedom gives p = .001. The check cannot tell whether the statistic or the p-value is the misprint.
Reported p < .001 · recomputed p = .001
“χ2(2) = 13.238, p < 0.001”
Inconsistent p-value: F(2,35) = 6.387, p = .005
MinorThe paper reports p = .005 here; recomputing from the test statistic and its degrees of freedom gives p = .004. The check cannot tell whether the statistic or the p-value is the misprint.
Reported p = .005 · recomputed p = .004
“F(2,35) = 6.387, p = 0.005”
Inconsistent p-value: F(2,32) = 6.205, p = .006
MinorThe paper reports p = .006 here; recomputing from the test statistic and its degrees of freedom gives p = .005. The check cannot tell whether the statistic or the p-value is the misprint.
Reported p = .006 · recomputed p = .005
“F(2,32) = 6.205, p = 0.006”
Inconsistent p-value: F(2,34) = 3.181, p = .055
MinorThe paper reports p = .055 here; recomputing from the test statistic and its degrees of freedom gives p = .054. The check cannot tell whether the statistic or the p-value is the misprint.
Reported p = .055 · recomputed p = .054
“F(2,34) = 3.181, p = 0.055”
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upχ²(2) = 13.238reported p < .001 · recomputed p = .001
“χ2(2) = 13.238, p < .001”
- Doesn’t add upF(2, 34) = 3.181reported p = .055 · recomputed p = .054
“F(2,34) = 3.181, p = .055”
- Doesn’t add upF(2, 32) = 6.205reported p = .006 · recomputed p = .005
“F(2,32) = 6.205, p = .006”
- Doesn’t add upt(22) = 2.65reported p < .001 · recomputed p = .015
“t(22) = 2.650, p < .001”
- Doesn’t add upF(2, 35) = 6.387reported p = .005 · recomputed p = .004
“F(2,35) = 6.387, p = .005”
- ConsistentF(2, 35) = 5.464reported p = .009 · recomputed p = .009
“F(2,35) = 5.464, p = .009”
- Consistentχ²(1) = 6.367reported p = .012 · recomputed p = .012
“χ2(1) = 6.367, p = .012”
- Consistentχ²(2) = 6.28reported p = .043 · recomputed p = .043
“χ2(2) = 6.280, p = .043”
- Consistentχ²(2) = 12.826reported p = .002 · recomputed p = .002
“χ2(2) = 12.826, p = .002”
- ConsistentF(2, 33) = 3.87reported p = .031 · recomputed p = .031
“F(2,33) = 3.870, p = .031”
- ConsistentF(2, 33) = 3.387reported p = .046 · recomputed p = .046
“F(2,33) = 3.387, p = .046”
- Consistentt(22) = -2.303reported p = .031 · recomputed p = .031
“t(22) = − 2.303, p = .031”
- Consistentt(22) = -3.583reported p = .002 · recomputed p = .002
“t(22) = − 3.583, p = .002”
- ConsistentF(2, 34) = 5.412reported p = .009 · recomputed p = .009
“F(2,34) = 5.412, p = .009”
- Consistentt(21) = -2.589reported p = .017 · recomputed p = .017
“t(21) = − 2.589, p = .017”
- ConsistentF(2, 32) = 7.006reported p = .003 · recomputed p = .003
“F(2,32) = 7.006, p = .003”
- ConsistentF(2, 34) = 8.709reported p < .001 · recomputed p < .001
“F(2,34) = 8.709, p < .001”
- ConsistentF(2, 34) = 7.548reported p = .002 · recomputed p = .002
“F(2,34) = 7.548, p = .002”
- ConsistentF(2, 31) = 3.42reported p = .046 · recomputed p = .045
“F(2,31) = 3.420, p = .046”
- Consistentt(21) = 2.65reported p = .015 · recomputed p = .015
“t(21) = 2.650, p = .015”
- Consistentt(22) = -1.937reported p = .066 · recomputed p = .066
“t(22) = − 1.937, p = .066”
- Consistentt(22) = 2.907reported p = .008 · recomputed p = .008
“t(22) = 2.907, p = .008”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 3 caption and results assign different outcomes to panels
MinorThe caption assigns panels e and f to neutrophils and CXCL1, while the results cite those panels for circulating Treg cells and IL-10.
“Similarly, neutrophil (CD11b+, LY6Cmid, SSChigh and CXCL1 levels were also investigated in peripheral blood (e, f).”
“The effects of UK4 also reached the peripheral circulation, where there was an increased prevalence of Treg cells (F(2,31) = 3.420, p = 0.046) (Fig. 3e). Similarly, we observed increased plasma IL-10 levels (F(2,32) = 6.205, p = 0.006) (Fig. 3f)”
Ileal functional separation is called significant at p = 0.052
MinorThe results call the ileal Fr1 separation significant, although its reported p value is above the paper's stated significance threshold.
“Fr1 induced a significant functional separation in the microbiome in the ileum (p = 0.052, R2 = 0.099) and the caecum (p = 0.019, R2 = 0.079), but not in the faeces (p = 0.108, R2 = 0.068) (Fig. 7a).”
“A p value < 0.05 was deemed significant”
Saccharin-preference formula uses sucrose intake
MinorThe test administers saccharin solution, but its stated preference formula uses sucrose intake as the numerator.
“Saccharin preference was calculated using the following formula: Total sucrose intake/total fluid intake × 100%.”
“Hereafter, one drinking water bottle was replaced by one containing a saccharin solution (0.1% w/v) for 24 h.”
Discussion calls beta-diversity separation significant despite reported p-value range
MinorThe discussion says kefir overall produced significant beta-diversity separation, but the results give a p-value range entirely above 0.05 for all regions.
“Analysis of beta diversity revealed a trend towards significant separation induced by both Fr1 and UK4, which resulted in a significant separation induced by kefir overall.”
“It is notable that, the kefir treatment overall did influence beta diversity (p value ranged from 0.05 < p ≤ 0.10 for all regions).”
Discussion reverses Fr1's reported effect on neutrophils and CXCL1
MinorThe results report that Fr1 ameliorated elevations in neutrophils and CXCL1, but the discussion says Fr1 increased both.
“Furthermore, Fr1 increased circulating neutrophil and CXCL1 levels.”
“For instance, Kefir Fr1 increased reward-seeking behaviour and ameliorated stress-induced increases in circulating neutrophil and CXCL1 levels.”
The citation lists haven’t been fetched yet
References 90 · Cited by 123
Research works printed but not linked: 1
- Oksanen J, Kindt R, Legendre P, O’Hara B, Stevens MHH, Oksanen MJ, Suggests M. The vegan package. Comm Ecol Package. 2007;10:631–7.
- Authors
- van de Wouw, M., Walsh, A. M., Crispie, F., van Leuven, L., Lyte, J. M., Boehme, M., Clarke, G., Dinan, T. G., Cotter, P. D., & Cryan, J. F.
- Affiliations
- Teagasc - The Irish Agriculture and Food Development Authority (IE)
- University College Cork (IE)
- Corresponding author
- Cotter, Paul D.
- Cryan, John F.
- ORCID
- Venue
- Microbiome
- Published
- 2020-05-18
- Volume
- 8
- Issue
- 1
- Pages
- 67-67
- ISSN
- 2049-2618 (ISSN-L)
- PMC
- PMC7236220
- OpenAlex
- W3026259629
- Semantic Scholar
- bce58de2464961f3f5f687be5d25fae25a50e632
- Cited by
- 123
- References
- 90
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 30 · 2023: 18 · 2022: 13 · 2021: 16 · 2020: 3 · 2019: 1 · 2017: 1
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Microbiome (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- T-Stór (Teagasc) (submittedVersion, cc-by-nc-sa)
- Funders
- Science Foundation Ireland (SFI/12/RC/2273, 15/JP‐HDHL/3270)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- kefir, fermented milk beverages, gut microbiota, gut-brain axis, psychobiotics, host behavior, stress, reward-seeking behavior, repetitive behavior, contextual fear memory, spatial learning, serotonin, regulatory T cells, IL-10, neutrophils, CXCL1, GABA production, Lactobacillus reuteri
- MeSH terms
- Gastrointestinal Microbiome, Kefir, Host Microbial Interactions, Animals, Behavior, Animal, Male, Mice, Inbred C57BL, Mice, Microbial Interactions, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review